Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adagio Medical Holdings, Inc - Common Stock (NQ:ADGM)

1.140 -0.030 (-2.56%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical Expands Chief Business Officer Deborah Kaster’s Role to Include Chief Financial Officer Responsibilities
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical Reports Second Quarter 2025 Results
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical Reports First Quarter 2025 Results
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical to Present at the BofA Securities 2025 Health Care Conference
From Adagio Medical
Via Business Wire
Health In Tech (NASDAQ: HIT) Expands AI-Powered Insurance Platform – Zacks Report & More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Economy
Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical Appoints Deborah Kaster as Chief Business Officer
From Adagio Medical
Via Business Wire
Adagio Medical Reports Fourth Quarter and Full Year 2024 Results
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical Provides Clinical and Business Updates
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical Reports Third Quarter 2024 Results
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical to Present at the Stifel 2024 Healthcare Conference
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias
From Adagio Medical Holdings, Inc.
Via Business Wire
Adagio Medical Provides Business Updates
From Adagio Medical Holdings, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.